US and EU Mechanical Ventilators Market to hit US$ 14.03 Billion by 2033 | Top Companies are ResMed, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and ZOLL Medical Corporation

US and EU mechanical ventilators market size reached US$ 7.54 Billion in 2024 from US$ 7.07 Billion in 2023 and is expected to reach US$ 14.03 Billion by 2033, growing at a CAGR of 7.2% during the forecast period 2025-2033.

DataM Intelligence unveils its latest report on the "US and EU Mechanical Ventilators Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

About 11.1 million U.S. adults were diagnosed with COPD, with women (4.1%) affected more than men (3.4%). The condition rises sharply with age, hitting 10.5% in those 75+. In Europe, over 36 million people suffer from COPD, with higher rates in men (3,230 per 100,000) than women (2,202 per 100,000), says the EFA.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/us-and-eu-mechanical-ventilators-market?kb

Key Market highlights:

The US leads the mechanical ventilators market in both the US and EU regions, holding the highest revenue share of 64.07% in 2024.

Among product types, the critical care ventilators segment dominates the market, capturing the largest revenue share of 53.76% in 2024.

List of Top Key Player:

Hamilton Medical, Drägerwerk AG & Co. KGaA, Getinge, Medtronic, Koninklijke Philips N.V., GE HealthCare, ResMed, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and ZOLL Medical Corporation

Industry Developments:

In November 2024, CorVent Medical announced FDA 510(k) clearance for its RESPOND ventilator, a cost-effective device designed to provide simple, safe, and intelligent ventilation, thereby improving access to quality care for healthcare providers and patients.

Similarly, Dräger's Evita V600 and V800 series received 510(k) clearance in 2023, highlighting ongoing regulatory support for critical care and transport-ready ventilators. Leading U.S. companies such as Philips, GE HealthCare, and CorVent Medical have utilized this regulatory momentum to launch innovative products like Philips Trilogy Evo for home and chronic care, GE CARESCAPE R860 for ICU integration with hospital IT systems, and CorVent RESPOND for rapid deployment in acute care environments.

Forecast Projection:

The US and EU Mechanical Ventilators Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The US and EU Mechanical Ventilators Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Latest M&A

Major M&A activity includes partnerships like Medline's exclusive deal with Flight Medical for transport ventilators in the US and ongoing consolidation among key players like GE Healthcare, Philips, Dräger, ResMed, and Vyaire.

Investments focus on expanding portable, non-invasive, and AI-integrated ventilator portfolios to meet diverse clinical needs.

Private equity involvement and cross-border deals strengthen technological development and market reach in the US and Europe.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=us-and-eu-mechanical-ventilators-market?kb

Key Segmentation:

By Product Type: (Critical Care Ventilators, Neonatal Ventilators, and Transport & Portable Ventilators)

By Ventilation Mode: (Invasive and Non-Invasive)

By End-User: (Hospitals, Ambulatory Surgery Centers, Home Care Settings, and Others)

Latest FDA Approvals

CorVent Medical's RESPOND ventilator received FDA 510(k) clearance in November 2024, noted for safe and smart ventilation accommodating invasive/non-invasive modes.

Dräger's Evita V600 and V800 ventilators obtained FDA clearance in 2023, facilitating critical care and transport-ready applications.

Ongoing regulatory approvals focus on cost-effective, portable, and telehealth-enabled ventilation devices enhancing access and flexibility.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/us-and-eu-mechanical-ventilators-market?kb

FAQ's

Q1: How large is the US and EU Mechanical Ventilators Market?

Ans: The US and EU Mechanical Ventilators Market size was valued at USD$ 7.54 Billion in 2024 and is projected to grow to USD $ 14.03 Billion by 2033.

Q2: How quickly is the US and EU Mechanical Ventilators Market expanding?

Ans: The US and EU Mechanical Ventilators Market is forecasted to grow at a CAGR of 7.2% between 2024 and 2031, showing strong growth momentum

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/us-and-eu-mechanical-ventilators-market?kb

Reimbursement

CMS introduced a final National Coverage Determination in June 2025 expanding Medicare coverage for home mechanical ventilators and respiratory assist devices with enhanced billing codes, eliminating trial requirements for certain devices.

The updated policy supports coverage upon hospital discharge with six-month renewal based on clinical assessment, streamlining access and reimbursement pathways.

Reimbursement covers acute, chronic, and ambulatory care settings with specific CPT and ICD-10 codes for device operation, maintenance, and related services.

Payer models are shifting toward value-based frameworks emphasizing patient outcomes and cost efficiency.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.